Response Oncology (Response Oncology) Capex-to-Operating-Cash-Flow : 0.01 (As of Mar. 2002)

Response Oncology Capex-to-Operating-Cash-Flow Chart

Response Oncology Annual Data
	Trend	Dec92	Dec93	Dec94	Dec95	Dec96	Dec97	Dec98	Dec99	Dec00	Dec01
Capex-to-Operating-Cash-Flow		Get a 7-Day Free Trial					0.15	0.61	0.06	0.13	0.01

Response Oncology Quarterly Data
	Jun97	Sep97	Dec97	Mar98	Jun98	Sep98	Dec98	Mar99	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02
Capex-to-Operating-Cash-Flow	Get a 7-Day Free Trial															0.01	0.01	-	0.01	0.01

Competitive Comparison of Response Oncology's Capex-to-Operating-Cash-Flow

For the Medical Care Facilities subindustry, Response Oncology's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Response Oncology's Capex-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Response Oncology's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Response Oncology's Capex-to-Operating-Cash-Flow falls into.

Response Oncology Capex-to-Operating-Cash-Flow Calculation

Response Oncology's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2001 is calculated as

Response Oncology's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2002 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Oncology  (GREY:ROIX) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.

Response Oncology Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Response Oncology's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Response Oncology (Response Oncology) Business Description